The provision of help from T cells to B cells is a critical component of adaptive humoral immunity 1,2 . During viral infection, the formation of germinal centers (GCs) by antigen-specific B cells requires key signals provided by follicular helper T cells (T FH cells) 3 , which results in the development of high-affinity long-lived plasma cells and memory B cells 4, 5 . The differentiation of T FH cells begins outside of B cell follicles in a stepwise fashion. Early induction of molecules key to T FH differentiation, such as the transcriptional repressor Bcl6, the chemokine receptor CXCR5, the costimulatory receptor ICOS and the T cell-inhibitory receptor PD-1, occurs in the T cell zone when CD4 + T cells interact with antigen-presenting dendritic cells or other antigen-presenting cells, which then enable migration of the activated CD4 + T cells toward the border of B cell follicles. Upon recognizing cognate antigen-presenting B cells, the differentiating T FH cells migrate deep inside B cell follicles and further differentiate into GC T FH cells as they direct the generation of GC B cells.
The provision of help from T cells to B cells is a critical component of adaptive humoral immunity 1, 2 . During viral infection, the formation of germinal centers (GCs) by antigen-specific B cells requires key signals provided by follicular helper T cells (T FH cells) 3 , which results in the development of high-affinity long-lived plasma cells and memory B cells 4, 5 . The differentiation of T FH cells begins outside of B cell follicles in a stepwise fashion. Early induction of molecules key to T FH differentiation, such as the transcriptional repressor Bcl6, the chemokine receptor CXCR5, the costimulatory receptor ICOS and the T cell-inhibitory receptor PD-1, occurs in the T cell zone when CD4 + T cells interact with antigen-presenting dendritic cells or other antigen-presenting cells, which then enable migration of the activated CD4 + T cells toward the border of B cell follicles. Upon recognizing cognate antigen-presenting B cells, the differentiating T FH cells migrate deep inside B cell follicles and further differentiate into GC T FH cells as they direct the generation of GC B cells.
The requirement for repeated interactions with antigen-presenting cells is an important feature of the differentiation of T FH cells 3 , which is presumably connected to maintenance of the activity of critical transcription factors such as Bcl6 (refs. 6-8) , Batf 9 , STAT3 (refs. [10] [11] [12] , STAT1 (ref. 10 ) and Ascl2 (ref. 13 ) that support such differentiation. Among those, Bcl6 function is absolutely critical. T FH differentiation is completely abrogated in Bcl6 −/− CD4 + T cells [6] [7] [8] , and ectopic Bcl6 expression in CD4 + T cells leads to augmented T FH differentiation 6, 9 . Various signaling molecules have been identified that can regulate Bcl6 expression in CD4 + T cells 14 . However, attempts to polarize CD4 + T cells to T FH cells in vitro through the use of interleukin 6 (IL-6) and IL-21 have failed to reproducibly induce the expression of Bcl6 and CXCR5. Therefore, there are clear gaps in the understanding of the molecular requirements for Bcl6 induction and the factors that support T FH differentiation 3 .
LEF-1 (encoded by Lef1) and TCF-1 (encoded by Tcf7) are transcription factors that contain a conserved high-mobility-group DNA-binding domain. TCF-1 and LEF-1 are known for their essential roles in early T cell development, including specification to the T cell lineage and β-selection during the CD4 − CD8 − double-negative stage 15, 16 . TCF-1 and LEF-1 critically regulate commitment to the CD4 + T cell lineage versus commitment to the CD8 + T cell lineage upon completion of positive selection of CD4 + CD8 + double-positive thymocytes 17, 18 . In mature CD8 + T cells, TCF-1 and LEF-1 regulate the generation, maturation and longevity of memory CD8 + T cells in response to viral or bacterial infection [19] [20] [21] . In mature CD4 + T cells, TCF-1 promotes differentiation into the T H 2 subset of helper T cells in vitro via positive regulation of the transcription factor GATA-3 (ref. 22) . TCF-1 restrains the expression of IL-17A in developing thymocytes and activated CD4 + T cells 23 . In addition, TCF-1 can interact with the transcription factor Foxp3 and seems to oppose Foxp3-mediated repression of genes in CD4 + regulatory T cells 24 .
Here we looked for undiscovered regulators of early T FH differentiation and found that LEF-1 and TCF-1 were critical transcriptional regulators of such differentiation. Through the use of a knock-in reporter system and high-throughput sequencing for cDNA (RNA-seq), we found that these transcription factors had high expression in T FH cells after viral or bacterial infection. Deletion of Lef1 or Tcf7 or both in CD4 + T cells led to defects in T FH differentiation in a dose-dependent manner. As a consequence, the magnitude of B cell responses and GC reactions was substantially diminished in mice deficient in LEF-1 and/or TCF-1, after infection. Mechanistically, LEF-1 and TCF-1 regulated multiple interacting mechanisms upstream of Bcl6 to 'preferentially' instruct activated CD4 + T cells to undertake T FH differentiation.
RESULTS

Transcriptional profiles of early T FH cells versus T H 1 cells
The initial contact of CD4 + T cells with antigen-presenting cells in the T cell zone can promote the expression of key T FH cell molecules, including Bcl6 and CXCR5. By 72 h into an acute viral infection, the early T FH cells and T H 1 cells have become committed to their fate 25, 26 . Early T FH cells are IL-2Rα lo Bcl6 hi Blimp1 − CXCR5 hi , while early T H 1 cells are IL-2Rα + and T-bet hi Bcl6 − Blimp1 hi in the context of acute viral or bacterial infection [25] [26] [27] [28] . To identify additional factors important in the programming of T FH cells, we performed gene-expression analysis of early T FH cells and T H 1 cells by RNA-seq. For this we used cells from SMARTA mice (which have transgenic expression of a T cell antigen receptor specific for the lymphocytic choriomeningitis virus (LCMV) gp61 epitope) with the additional modification of replacement of coding sequence in one allele of the endogenous gene Prdm1 (which encodes the transcription factor Blimp1) with sequence encoding yellow fluorescent protein (Blimp1-YFP). We transferred congenically marked (CD45.1 + ) CD4 + T cells from those mice into C57BL/6 (B6) (CD45.2 + ) host mice and then acutely infected the host mice with the Armstrong strain of LCMV. We isolated early T FH cells and T H 1 cells 3 d after infection and purified the cells to homogeneity by sorting IL-2Rα − Blimp1-YFP − cells and IL-2Rα + Blimp1-YFP + cells, respectively. We performed RNA-seq on RNA isolated from the cells and obtained transcriptome profiles of early T FH cells and T H 1 cells (Fig. 1a,b) . Our analysis revealed that approximately 1,200 genes were upregulated more than 1.5-fold in early T FH cells relative to their expression in T H 1 cells, and 1,600 genes were downregulated more than 1.5-fold (Fig. 1b) . Early T FH cells expressed many genes that are also 'preferentially' expressed by fully differentiated T FH cells and GC T FH cells (Bcl6, Cxcr5, Pdcd1, Pou2af1 and Tnfsf8, among others) and had low expression of many genes repressed in fully differentiated T FH cells and GC T FH cells (Prdm1, Tbx21, IL2ra, Gzmb and Prf1, among others) (Fig. 1a,b) . Thus, major attributes of T FH and T H 1 cells were transcriptionally well defined by day 3 of an acute viral infection.
LEF-1 is a transcriptional regulator of T FH differentiation
To further filter the 2,800 gene-expression differences between early T FH cells and T H 1 cells, we focused on transcription factors. We performed an additional set of RNA-seq experiments with CD4 + T cells activated in vitro under T H 1-polarizing conditions (IL-12 plus antibody to IL-4 (anti-IL-4) plus antibody to transforming growth factor-β) or with IL-6 (IL-6 plus antibody to interferon-γ plus anti-IL-12). We used these screening conditions because in vitro stimulation of CD4 + T cells in the presence of IL-6 resulted in some gene-expression changes associated with T FH differentiation ( Supplementary  Fig. 1a-c) . Most notably, Il21 was robustly induced by IL-6; however, Fig. 1f ). This outcome suggested that key transcriptional regulators required for T FH differentiation were not induced under IL-6 conditions in vitro.
We next performed a comparative analysis of gene-expression differences between the early T FH cells generated in vivo and the CD4 + T cells stimulated in vitro with IL-6. To find critical previously unidentified early upstream transcriptional regulators of T FH differentiation, we focused on genes that met two conditions: 'preferential' expression by early T FH cells in vivo and lack of a difference in expression after in vitro stimulation with IL-6, relative to expression after stimulation without IL-6. Lef1 satisfied these two conditions ( Fig. 1b and Supplementary Fig. 1d,g ), and we selected it for further analysis in part because LEF-1 is required for the formation of memory CD8 + T cells 20 and there are similarities between the differentiation of T FH cells and that of memory CD8 + T cells 25, 31 . When expressed in SMARTA CD4 + T cells, a retroviral vector expressing microRNA-adapted short hairpin RNA (shRNAmir) targeting Lef1 (shLef1) inhibited expression of both isoforms of LEF-1 protein (Fig. 1c) (Fig. 1e) or IL-2Rα − CXCR5 + cells (Fig. 1f) . The effect of the knockdown of LEF-1 was selective to T FH differentiation, as the activation of SMARTA CD4 + T cells (as assessed by upregulation of expression of the activation marker CD44; data not shown) and proliferation ( Fig. 1d) were similar for shCtrl + CD4 + T cells and shLef1 + CD4 + T cells. The reduced T FH differentiation of shLef1 + CD4 + T cells indicated that LEF-1 might be an important and dose-limiting contributor to this process.
LEF-1 controls T FH differentiation and GC formation
We next investigated whether LEF-1 function in CD4 + T cells was important for GC T FH differentiation and GC reactions. We transferred shLef1 + or shCtrl + SMARTA CD4 + T cells into B6 mice and analyzed the recipient mice 8 d after acute infection with LCMV. The activation and proliferation of CD4 + T cells were not affected by reduced Lef1 expression, compared with that of shCtrl + CD4 + T cells (Fig. 2a) , but the T FH differentiation of shLef1 + cells was impaired (Fig. 2b,c) . The T FH -differentiation defect of shLef1 + cells was less severe at day 8 than that observed on day 3 (Fig. 2b) , potentially due to the fact that sustained gene knockdown in CD4 + T cells in vivo is difficult to accomplish under conditions of rapid proliferation. We observed milder T FH -differentiation defects for most retrovirusexpressed shRNAmirs, including shRNAmir directed against Bcl6, at peak proliferation time points than at early time points after infection (data not shown). Nevertheless, shLef1 + SMARTA CD4 + T cells showed defective differentiation into GC T FH cells, identified here as PSGL-1 lo CXCR5 + T cells (Fig. 2d) or Bcl6 + CXCR5 + T cells (Fig. 2e) , compared with such differentiation of shCtrl + SMARTA CD4 + T cells. As a result, the development of GC B cells (Bcl6 + CD19 + ) was moderately impaired in the presence of shLef1 + SMARTA CD4 + T cells relative to their development in the presence of shCtrl + cells (Fig. 2f) . npg promoter (Cd4-Cre) impairs CD4 + T cell lineage 'choice' and diminishes the output of CD4 + T cells 18 . To avoid this, we used mice with transgenic expression of Cre driven by the promoter of the human gene encoding the activation-costimulation molecule CD2 (hCD2-Cre), which results in gene ablation in mature T cells 32 . We also crossed mice to mice expressing an allele for the expression of green fluorescent protein (GFP) from the ubiquitously expressed 'Rosa26' locus (Rosa26-STOP-GFP; called 'Rosa26 GFP ' here). As marked by GFP expression due to excision of the loxP-flanked transcription-translation 'stop' sequence from the Rosa26 GFP allele, over 70% of splenic CD4 + T cells in Rosa26 GFP hCD2-Cre + mice were GFP + , whereas less than 15% of CD4 + thymocytes were GFP + ( Supplementary Fig. 2a ).
We crossed Rosa26 GFP hCD2-Cre + mice to the Fig. 2g ). In contrast, the number of SLAM − CXCR5 + T FH cells was more markedly diminished in vaccinia virus-infected Lef1 −/− mice compared with the number of these cells in their infected control littermates (Fig. 3a) . In particular, the number of GC T FH cells was considerably lower in Lef1 −/− mice than in their control littermates (by Bcl6 + CXCR5 + and PD-1 hi CXCR5 + phenotyping; Fig. 3b,c) . These data further supported the proposal of role for LEF-1 in directing the differentiation of T FH cells.
TCF-1 expression is retained in T FH cells but not in T H 1 cells
RNA-seq analysis of early T FH cells and T H 1 cells isolated from B6 mice revealed that Tcf7 also had high expression in early T FH cells, but Tcf7 was not induced by in vitro stimulation of CD4 + T cells with IL-6 ( Fig. 1b and Supplementary Fig. 1e,g ). Given that LEF-1 and TCF-1 are related transcription factors, we investigated whether TCF-1 was also an early regulator of T FH differentiation. For this purpose, we generated mice with sequence encoding GFP inserted into the Tcf7 locus (Tcf7 GFP ; Supplementary Fig. 4a ). The Tcf7-GFP reporter had abundant expression in CD4 + T cells, CD8 + T cells and CD4 + CD25 + regulatory T cells but was absent in B220 + cells ( Supplementary  Fig. 4b-d) , which demonstrated the reporter fidelity. The expression of Tcf7-GFP was highest in CD44 lo CD62L + naive T cells but was moderately diminished in antigen-experienced T cell subsets such as CD44 hi CD62L + memory-phenotype T cells, and particularly CD44 hi CD62L − effector-phenotype T cells ( Supplementary Fig. 4b,c) .
To analyze TCF-1 expression kinetics in antigen-specific CD4 + T cells, we generated Tcf7 GFP/+ SMARTA mice and adoptively transferred naive CD44 lo CD62L + CD45.2 + CD4 + T cells from those mice into CD45.1 + congenic recipients. Following infection with LCMV, Tcf7-GFP expression was greatly diminished in SLAM hi CXCR5 − T H 1 cells relative to its expression in naive CD4 T cells by day 8 after infection, while Tcf7-GFP expression was maintained at a high level by most SLAM lo CXCR5 + T FH cells (Fig. 4a) . We next investigated whether the retention of TCF-1 expression was associated with the T FH -differentiation program in response to other in vivo stimuli. Following adoptive transfer of Tcf7 GFP SMARTA CD4 + T cells, we infected recipient mice with Listeria monocytogenes expressing the gp61 epitope of LCMV. In other experiments, we directly infected Tcf7 GFP/+ mice with vaccinia virus, as a second viral infection model. Whereas SLAM hi CXCR5 − T H 1 cells that developed in both systems downregulated Tcf7-GFP expression, SLAM lo CXCR5 + T FH cells generated in response to both the bacterial and viral infections retained high expression of Tcf7-GFP ( Supplementary  Fig. 4e,f) . Given that TCF-1 is known to be markedly downregulated in effector CD8 + T cells 33 , these observations indicated that retention of TCF-1 expression at the effector phase of a T cell response was unique to T FH cells and further suggested a possible requirement for TCF-1 in T FH differentiation.
Both LEF-1 and TCF-1 are essential for T FH cell responses To address the role of TCF-1 in T FH cells, we generated Rosa26 GFP Tcf7 fl/ fl hCD2-Cre + mice (called 'Tcf7 −/− mice' here), in which all isoforms of TCF-1 were ablated in GFP + CD4 + T cells ( Supplementary  Fig. 2c ). To investigate the functional redundancy between LEF-1 and TCF-1, we also crossed Tcf7 −/− with Lef1 −/− mice to generate Lef1 −/− Tcf7 −/− mice (Rosa26 GFP Lef1 fl/fl Tcf7 fl/fl hCD2-Cre + ). Similar to Lef1 −/− mice, Tcf7 −/− mice and Lef1 −/− Tcf7 −/− mice did not have T cell-development defects or aberrant activation of mature T cells in (Supplementary Fig. 2 ). Although we observed slightly less thymic Fig. 2d,f,h,i) . We assessed the CD4 + T cell responses of Lef1 −/− Tcf7 −/− mice in response to infection with vaccinia virus. On day 8 after infection, analysis of CD44 hi CD62L − activated GFP + CD4 + T cells revealed that the frequency and number of SLAM lo CXCR5 + T FH cells were diminished in Tcf7 −/− mice compared with that of control mice (Fig. 4b) , with a comparable reduction in GC T FH cells (Bcl6 + CXCR5 + and PD-1 hi CXCR5 + phenotyping; Fig. 4c,d) . We found greater defects in Lef1 −/− Tcf7 −/− mice than in Tcf7 −/− mice ( Fig. 4b-d) , which indicated that both LEF-1 and TCF-1 contributed to regulating the differentiation of T FH cells . Consistent with the observations reported above, Tcf7 −/− and Lef1 −/− Tcf7 −/− mice exhibited a significantly lower frequency and number of GL7 + Fas + GC B cells than that of control mice (Fig. 4e) , with the most severe GC B cell defect in Lef1 −/− Tcf7 −/− mice (Fig. 4e) . The number of IgD lo CD138 + plasma cells was moderately reduced in Tcf7 −/− mice but was severely compromised in Lef1 −/− Tcf7 −/− mice, relative to that in their control littermates (Fig. 4f) . As a result, the production of vaccinia virus-specific antibodies was significantly impaired in Lef1 −/− Tcf7 −/− mice compared with that of their control littermates (P = 0.017; Supplementary Fig. 5 ). In summary, our data indicated critical roles for LEF-1 and TCF-1 in T FH differentiation and, consequently, B cell-helping functions, in a CD4 + T cell-intrinsic manner.
Ectopic Lef1 expression augments T FH differentiation
We next investigated whether enhanced expression of one of these transcription factors (LEF-1 and TCF-1) could augment the T FH differentiation of antigen-specific CD4 + T cells. Given that LEF-1 and TCF-1 exhibited overlapping activities in instructing the differentiation of T FH cells, we assessed the T FH differentiation of CD4 + T cells after ectopic expression of LEF-1. LEF-1 can be expressed as two isoforms in CD4 + T cells due to differential promoter use (Fig. 1c) , with the full-length isoform containing an amino-terminal β-catenin-binding domain. We constructed a retrovirus expressing full-length Lef1 (Lef1-RV) and confirmed increased expression of LEF-1 in Lef1-RV + SMARTA CD45.1 + CD4 + T cells by flow cytometry (Fig. 5a ) and immunoblot analysis (data not shown). We infected CD45.1 + SMARTA CD4 + T cells with control retrovirus expressing GFP alone (GFP-RV) or Lef1-RV and transferred the cells into B6 mice, which we then infected with LCMV. The overall activation and proliferation of Lef1-RV + CD4 + T cells was normal compared with that of GFP-RV + CD4 + T cells (Fig. 5b and data not shown). Ectopic LEF-1 expression resulted in enhanced T FH development of Lef1-RV + cells relative to that of GFP-RV + cells at 8 d after infection (Fig. 5c) . Moreover, we found that Lef1-RV + T H 1 cells (SLAM hi CXCR5 − ) unexpectedly exhibited higher expression of the canonical T FH molecules CXCR5 (Fig. 5d) and PD-1 (Fig. 5e) than that of their GFP-RV + counterparts. Most notably, GC T FH cells (with a phenotype of either PSGL-1 lo CXCR5 + or PD-1 hi CXCR5 + ) developed at a significantly higher frequency among Lef1-RV + SMARTA CD4 + T cells than among their GFP-RV + counterparts (Fig. 5f,g ). 
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-/-Tcf7 A r t i c l e s (Fig. 6b) . Given the induction of both Il6ra and Il6st (which encode the IL-6Rα and gp130 receptors for IL-6, respectively) in Lef1-RV + T H 1 cells and the fact that signaling via IL-6 receptors is one of the earliest signals that instruct T FH differentiation 3 , we investigated whether LEF-1-augmented T FH differentiation might be mediated through enhanced surface expression of IL-6Rα and gp130. We analyzed the expression of IL-6Rα and gp130 on the surface of Lef1-RV + or GFP-RV + SMARTA CD4 + T cells at day 3 after infection with LCMV, a time when signaling via IL-6 receptors is known to be critical for T FH differentiation 10 . The ectopic expression of LEF-1 in Lef1-RV + SMARTA CD4 + T cells resulted in higher expression of IL-6Rα than that on GFP-RV + SMARTA CD4 + T cells (Fig. 6c) . In a comparison of IL-6Rα expression on naive CD4 + T cells and that on activated Lef1-RV + or GFP-RV + SMARTA CD4 + T cells, we found that overexpression LEF-1 reduced the downregulation of IL-6Rα expression observed on activated GFP-RV + CD4 + T cells (Fig. 6c) . Overexpression of LEF-1 had a similar effect on gp130, reducing the downregulation of gp130 expression observed on activated GFP-RV + CD4 + T cells (Fig. 6d) . We then assessed the expression of IL-6Rα and gp130 on T FH and T H 1 subpopulations. We observed modestly higher IL-6Rα expression on T FH cells, whereas Lef1-RV + T H 1 cells expressed >150% more IL-6Rα than did GFP-RV + T H 1 cells (Fig. 6e) . While the expression of gp130 was only moderately higher on total Lef1-RV + SMARTA CD4 + T cells than on GFP-RV + SMARTA CD4 + T cells (Fig. 6d) , gp130 expression was 'preferentially' upregulated on Lef1-RV + T H 1 cells compared with its expression on GFP-RV + T H 1 cells (Fig. 6f) .
RNA-seq analysis also revealed that Icos expression was upregulated in Lef1-RV + T H 1 cells compared with its expression in GFP-RV + T H 1 cells (Fig. 6b) . Because ICOS has essential roles during both early stages and late stages of T FH differentiation 26 , we further assessed ICOS expression. Expression of ICOS protein was higher on Lef1-RV + T cells than on GFP-RV + cells (Fig. 6g) , and its upregulation occurred predominantly on Lef1-RV + T H 1 cells (Fig. 6h) , to levels comparable to those on GFP-RV + T FH cells. These observations indicated that LEF-1 functioned to help CD4 + T cells retain surface expression of IL-6 receptors and upregulate ICOS expression to enhance the responsiveness of activated CD4 + T cells to signaling via IL-6 and the ligand for ICOS, two essential signals for early T FH differentiation.
We then investigated whether overexpression of LEF-1 could restore T FH differentiation in the absence of Bcl6. Bcl6 fl/fl Cd4-Cre CD4 + T cells fail to differentiate into T FH cells during acute viral infection or immunization with protein 34 . Lef1-RV + or GFP-RV + Bcl6 fl/fl Cd4-Cre SMARTA CD4 + T cells transferred into B6 mice failed to differentiate into T FH cells in vivo at day 8 after infection of the recipient mice with LCMV (Supplementary Fig. 6 ). These results indicated that LEF-1-mediated regulation of the IL-6 receptor complex and ICOS expression acted upstream of Bcl6 expression early in T FH differentiation. (Fig. 7b) . Flow cytometry showed lower expression of gp130 and ICOS on Lef1 −/− Tcf7 −/− CXCR5 + T FH cells than on control T FH cells (Fig. 7c,d) . Although the decrease in Il6ra mRNA in Lef1 −/− Tcf7 −/− GC T FH cells did not reach statistical significance in the transcriptomic analysis, expression of IL-6Rα protein was consistently lower on Lef1 −/− Tcf7 −/− CXCR5 + T FH cells than on control T FH cells (Fig. 7e) . These observations indicated essential and overlapping roles for both LEF-1 and TCF-1 in supporting the expression of IL-6 receptors and ICOS during T FH differentiation. The abundance of Bcl6 transcripts was lower in PD-1 hi CXCR5 + GC T FH cells from Lef1 −/− Tcf7 −/− mice than in those from control mice, while the expression of Prdm1 was substantially elevated in Lef1 −/− Tcf7 −/− GC T FH cells (Fig. 7b) . Bcl6 and Blimp1 are known to have mutually antagonistic roles during T FH differentiation 6 . Blimp1 directly inhibits Bcl6 expression and is a potent inhibitor of T FH differentiation 6, 28, 30 . We confirmed the enhanced expression of Prdm1 in Lef1 −/− Tcf7 −/− PD-1 hi CXCR5 + GC T FH by quantitative PCR (Fig. 7f) .
This increase was specific to GC T FH cells (PD-1 hi CXCR5 + ) and T FH cells (PD-1 lo CXCR5 + ), because T H 1 cells (CXCR5 − ) from Lef1 −/− Tcf7 −/− mice and control mice had similar expression of Prdm1 (Fig. 7f) . The transcription factor Ascl2 is important in T FH differentiation 13 . Ascl2 expression was lower in Lef1 −/− Tcf7 −/− GC T FH cells than in control cells, but this reduction was less pronounced in PD-1 lo CXCR5 + T FH cells (Fig. 7f) . Expression of Rorc (which encodes the transcription factor RORγt) and Il17a was almost completely absent in control GC T FH cells, but these genes were expressed in Lef1 −/− Tcf7 −/− GC T FH cells (Fig. 7b) . Although the expression of genes characteristic of T H 17 cells is not normally observed after infection with vaccinia virus, our observations were in line with the known role of TCF-1 in restraining T H 17 differentiation 23 and indicated that LEF-1 and TCF-1 might suppress alternative helper T cell fates during T FH differentiation, perhaps in conjunction with Bcl6, which is also known to suppress alternative cell fates 3 
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Pou5f1) and key molecules of the Notch signaling pathway (decreased expression of Hes5 and Psen2, and increased expression of Rbpj) (Fig. 7b) . The role of these factors in T FH cells remains to be investigated. Overall, these observations suggested that LEF-1 and TCF-1 contributed to the regulation of many genes in activated, antigenspecific CD4 + T cells in vivo, including the positive regulation of Bcl6 and repression of Blimp1 to induce T FH differentiation.
Direct binding of TCF-1 to key T FH cell-associated genes
We used chromatin immunoprecipitation (ChIP) followed by deep sequencing (ChIP-seq) to determine whether LEF-1 and TCF-1 directly regulated the differentially expressed genes identified above. Both TCF-1 and LEF-1 have a highly homologous high-mobility-group DNA-binding domain that recognizes the same DNA consensus motif. Because reagents used for ChIP analysis of TCF-1 are of substantially higher quality than those available for such analysis of LEF-1, we focused on identifying TCF-1-bound genes in T FH cells. Because most T FH cells retained TCF-1 expression similar to that of naive CD4 + T cells (Fig. 4a) , we used our ChIP-seq data for TCF-1 that we obtained with naive wild-type CD4 + T cells (data not shown) as a reference for the identification of potential DNA-binding sites for TCF-1. We observed enrichment for binding of TCF-1 at the transcription start site (TSS) of IL6st, the TSS of Bcl6, a region 2.8 kilobases upstream of the Bcl6 TSS (-2.8 kb) and intron 3 of Prdm1 in naive CD4 + T cells, relative to its binding in the majority of the genome, but it was not associated with Il6ra or Ascl2 (Supplementary Fig. 7a ). We then performed ChIP analysis of TCF-1 in wild-type and Tcf7 −/− naive CD4 + T cells to ensure binding specificity. As a positive control, TCF-1 bound to the TSS of Axin2, a well-characterized TCF-1-responsive gene 15 , in wild-type naive CD4 + T cells, and this binding was completely abrogated in Tcf7 −/− naive CD4 + T cells (Fig. 8a) . In addition, T FH cells (CXCR5 + ) from B6 mice infected with vaccinia virus showed enrichment for the binding of TCF-1 to Axin2 relative to its binding in T H 1 cells (CXCR5 − ) from such mice (Fig. 8a) , consistent with higher expression of TCF-1 protein in T FH cells than in T H 1 cells. TCF-1 bound to Il6st in wild-type naive CD4 + T cells (Fig. 8b, right) , and T FH cells also showed enrichment for such binding relative to binding in the Tcf7 −/− negative control cells (Fig. 8b) . Although TCF-1 did not bind to Il6ra in wild-type naive CD4 + T cells, it was recruited to the Il6ra TSS in wild-type T FH cells (Fig. 8b, left) , which suggested that recruitment of TCF-1 to this site is part of the T FH differentiation program. Wild-type T H 1 cells did not exhibit enrichment for the binding of TCF-1 at Il6st or Il6ra compared with its binding in naive CD4 + T cells (Fig. 8b) , in line with the diminished expression of both IL-6Rα and gp130 on T H 1 cells (Fig. 7c,e) . We did not detect binding of TCF-1 to the TSS of Icos (Supplementary Fig. 7b ). These data suggested that TCF-1 directly regulated induction of the expression of IL-6 receptor chains to sustain expression of the IL-6 receptor complex by activated CD4 + T cells in vivo, which allowed T FH differentiation (Supplementary Fig. 8 ).
We next investigated by ChIP the association of TCF-1 with genes encoding transcription factors key to T FH differentiation. TCF-1 bound to intron 3 of Prdm1, the major regulatory site of Prdm1 expression 35 , in both naive CD4 + T cells and CXCR5 + T FH cells (Fig. 8d) , which suggested direct involvement of TCF-1 and its homolog LEF-1 in the suppression of Blimp1 in T FH cells. Given that Prdm1 is not expressed by naive CD4 + T cells, binding of TCF-1 at this site suggested that TCF-1 might antagonize Prdm1 expression upon T cell activation. In addition, we observed specific binding of TCF-1 to the TSS of Bcl6 and an upstream regulatory region of Bcl6 in naive CD4 + T cells (Fig. 8c) , and this binding pattern was maintained in T FH cells (Fig. 8c) . We observed robust enrichment for TCF-1 at Prdm1, Bcl6, Il6ra and a c 
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Ctrl Lef1 Il6st in wild-type T FH cells relative to its abundance at those genes in Tcf7 −/− T FH cells (Supplementary Fig. 7b ). We did not observe enrichment for TCF-1 binding in the Ascl2 TSS (Fig. 8c,d) , although we could not exclude the possibility that Ascl2 is regulated by LEF-1 and TCF-1 through more distal regulatory regions. Binding of TCF-1 to the upstream region of Bcl6 and the Prdm1 intron was abrogated in T H 1 cells relative to its binding in T FH cells (Fig. 8d) Fig. 8 ). 10 . In mice whose dendritic cells constitutively overexpress IL-6, the main alteration in phenotype observed is a substantial increase in T FH cells and GCs 36 . Therefore, regulation of the expression of IL-6 receptors on naive CD4 + T cells and early activated CD4 + T cells is a mechanism by which LEF-1 and TCF-1 influence T FH differentiation.
DISCUSSION
Bcl6 is essential for T FH differentiation, while Blimp1 is a powerful antagonist of such differentiation. Our observations that expression of LEF-1 resulted in aberrant expression of Bcl6 in T H 1 cells, Blimp1 expression was aberrantly upregulated in Lef1 −/− Tcf7 −/− GC T FH cells, and the genes encoding Bcl6 and Blimp1 were both targets directly bound by TCF-1 indicated that LEF-1 and TCF-1 probably dually regulate both of these critical transcription factors. While we cannot rule out the possibility that the de-repression of Prdm1 resulted from reduced Bcl6 expression in Lef1 −/− Tcf7 −/− T FH and GC T FH cells, we speculate that LEF-1 and TCF-1 directly repress Prdm1 expression. LEF-1 and TCF-1 are known to positively and negatively regulate gene expression, depending on the interacting factors. For examples, both proteins can interact with the coactivator β-catenin and with transcriptional corepressors of the TLE family, and LEF-1 and TCF-1 repress Cd4 in CD8 + T cells 18 . Future analysis of molecular mechanisms by which LEF-1 and TCF-1 regulate Prdm1 and Bcl6 will be important, as will analysis of how LEF-1 and TCF-1 interact with other regulators of Bcl6 and Prdm1, such as STAT1, STAT3, STAT5, Foxo1 and Klf2 (refs. 3,10,11,28,37,38) . Nevertheless, our data have provided proof that LEF-1 and TCF-1 regulate the balance between Bcl6 expression and Blimp1 expression.
ICOS expression was selectively impaired on Lef1 −/− Tcf7 −/− T FH cells, and ICOS expression was enhanced on Lef1-RV + cells. In multiple models, moderate changes in ICOS have been observed to enhance the differentiation of T FH cells [38] [39] [40] [41] or their function 42 . ICOS seems to be not a direct target of LEF-1 and TCF-1, although distal cis elements have not been explored. Alternatively, ICOS might be indirectly regulated by LEF-1 and TCF-1. Future studies should further elucidate the LEF-1 and TCF-1 signaling axes that modulate ICOS expression. Overall, the combined influence of LEF-1 and TCF-1 on IL-6Rα, gp130, Bcl6, Blimp1 and ICOS produces a dense network of interactions that create a strong pro-T FH cell signaling environment in a cell that sustains the expression of LEF-1 and/or TCF-1.
The functions of LEF-1 and TCF-1 probably continue to be important in fully differentiated T FH cells and GC T FH cells. LEF-1 and TCF-1 both continue to be expressed in GC T FH cells. Bcl6 expression is essential in GC T FH cells 3 , and continued regulation of both Bcl6 and Prdm1 are central aspects of GC T FH cell biology. ICOS is also a major regulator of GC T FH cell biology 26, 40 . Signaling via the IL-6 receptor is not usually essential in GC T FH cells due to compensatory abilities of IL-21 or IL-27 at later time points 29, 43, 44 . Nevertheless, the IL-6 receptor probably has a major role in sustaining GC T FH cells under normal physiological conditions. IL-6 is required for sustaining T FH cell and GC responses during chronic infection with LCMV in mice 45 , and IL-6 is positively associated with T FH cells and GCs in macaques positive for simian immunodeficiency virus 46 .
The activities of LEF-1 and TCF-1 seem to pre-program the responsiveness of a given naive CD4 + T cell to T FH cell signals, prior to any exposure of the cell to antigen. Therefore, we speculate that transient or sustained inflammatory or pathogenic conditions that alter the expression of LEF-1 or TCF-1 in naive T cells might have a global effect that alters the capacity of naive CD4 + T cells to respond to T FH cell-induction signals in the presence of pathogens or autoimmunity triggers. Ultimately, it will be useful to determine how homeostatic signals act in concert with LEF-1 and TCF-1 to modulate the 47 . We speculate these processes may be interrelated.
In conclusion, our study has identified previously unknown roles for LEF-1 and TCF-1 in T FH differentiation. Better understanding of the downstream targets of LEF-1 and TCF-1 in activated CD4 + T cells will improve the understanding of T FH cell biology. Finally, better understanding of the signals that regulate LEF-1 and TCF-1 will have implications for understanding how to enhance or inhibit the differentiation of T FH cells.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. GEO: RNA-seq data, GSE66781 and GSE67336. T FH cells and T H 1 cells: poly(A) RNA was isolated from 200 ng total RNA of each sample through the use of a Poly(A) Purist MAG kit (AM1922; Ambion). The resulting poly(A) RNA was then fragmented and prepared according to the manufacturer's instructions (ABI 4452437 Rev B), into 'bar-coded' , strand-specific libraries with The SOLiD Total RNA-seq Kit (ABI 4445374). Following library preparation, 15 ng of each library was converted into SOLiD Wildfire compatible fragments with a 5500 W Conversion Primer Kit (Life Technologies) and five rounds of PCR. Libraries were then pooled at equimolar concentrations with a Quant-iT PicoGreen dsDNA Assay Kit (Life Technologies) and were sequenced on a 5500XL W Genetic Analyzer (Life Technologies). SOLiD 5500-2 sequencing outcomes were converted from 'color space' to 'nucleotide space' through the use of solid2fastq script (Galaxy). For RNA-seq analysis of GFP-RV + or Lef1-RV + SMARTA cells obtained 4 d after infection with LCMV, 500 ng of each sample's total RNA was prepared into mRNA libraries according to manufacturer's instructions (RS-122-2103; Illumina). The resulting libraries were deep sequenced on an Illumina 2500 in Rapid Run Mode, through the use of single-end reads with a length of 50 nucleotides (>24 × 10 6 reads per condition). The single-end reads that passed Illumina filters were filtered for reads aligning to tRNA, rRNA, adaptor sequences, and 'spike-in' controls.
The reads were then aligned to the UCSC mm9 reference genome through the use of TopHat software (version 1.4.1). 'DUST scores' (for filtering lowcomplexity regions) were calculated with PRINSEQ Lite data preprocessing software (version 0.20.3), and low-complexity reads (with a 'DUST score' of >4) were removed from the BAM files (binary alignment map). The alignment results were parsed via SAMtools to generate SAM files (sequence alignment map). Read counts to each genomic feature were obtained with the htseqcount program (version 0.6.0) with the 'union' option. After removal of absent features (zero counts in all samples), the raw counts were then imported to software of the R project for statistical computing (R/Bioconductor package DESeq2) for the identification of genes differentially expressed among samples. DESeq2 normalizes counts by dividing each column of the 'count table' (samples) by the size factor of the column. The size factor is calculated by division of the samples by geometric means of the sequence reads of the genes. This brings the count values to a common scale suitable for comparison. P values for differential expression were calculated with the binomial test for differences between the base means of two conditions. These P values were then adjusted for multiple-test correction with the Benjamini-Hochberg algorithm to control the false-discovery rate. We considered genes as being expressed differentially between two groups of samples when the DESeq2 analysis resulted in an adjusted P value of <0.05 and the difference in gene expression was 1.5-fold. Cluster analyses, including principal-component analysis and hierarchical clustering, were performed with standard algorithms and metrics. Hierarchical clustering was performed with complete linkage with Euclidean metric.
Heat maps. Heat maps were generated with normalized data of RNA-seq analyses for early T FH cells and T H 1 cells and for GFP-RV + and Lef1-RV + T FH cells and T H 1 cells. Microarray analysis used published T H 1 cell sets, T FH cell sets and GC T FH cell sets (GEO accession code GSE21380) 51 and the GenePattern software suite (Broad Institute).
GSEA. GSEA was performed with GSEA software from the Broad Institute. Gene sets were generated in-house with genes that had a difference in expression of more than twofold in T FH cells (PD-1 lo CXCR5 + ) and GC T FH cells (PD-1 hi CXCR5 + ) relative to their expression in T H 1 cells (PD-1 − CXCR5 − ) (GEO accession code GSE21380). Enrichment for genes that were upregulated more than 1.2-fold in Lef1-RV + T H 1 cells relative to their expression in GFP-RV + T H 1 cells was then ranked by the 'Diff_of_Classes' metric of GSEA software.
ChIP. Sorted CD4 + T cells were cross-linked for 5 min with 1% formaldehyde in medium, were processed with a truChIP Chromatin Shearing Reagent Kit (Covaris) and were sonicated for 5 min on Covaris S2 ultrasonicator. The sheared chromatin was immunoprecipitated with anti-TCF-1 (C46C7; Cell Signaling Technologies) or control rabbit immunoglobulin G (2729; Cell Signaling Technologies) and was washed as described 18 . The immunoprecipitated DNA segments were used for quantification by PCR. For calculation of enrichment in the binding of TCF-1 in a given cell type, each ChIP sample analyzed with TCF-1 was first normalized to corresponding ChIP sample analyzed with immunoglobulin G, and the signal at a target region was then normalized to that at the Hprt promoter region.
Statistical analysis. Data sets were analyzed with the Student's t-test with a two-tailed distribution assuming equal sample variance.
